2024 Annual Meeting | N2 - Neuroscience in the Clinic: Neuromodulation: From Bench to Bedside
| 01:00 PM - 01:03 PM MDT | Introduction |
Introduction
Joshua M. Shulman, MD, PhD, FAAN |
| 01:03 PM - 01:28 PM MDT | Speaker |
Blood-brain Barrier: Friend and Foe—Towards Targeted, Noninvasive Study and Repair of Nervous Systems
Viviana Gradinaru, PhD |
| 01:28 PM - 01:53 PM MDT | Speaker |
Ultrasonic Drug Uncaging for Noninvasive Targeted Neuro-pharmacology
Raag Airan |
| 01:53 PM - 02:18 PM MDT | Speaker |
Circuit-Inspired Strategies to Improve Treatments for Parkinson’s Disease
Aryn Gittis |
| 02:18 PM - 02:30 PM MDT | Abstract |
001 - Phase 1b Safety and Preliminary Efficacy of Bilateral Intraputaminal Delivery of AAV2 GDNF (AB-1005) in Participants With Mild or Moderate Parkinson’s Disease
Amber D. Van Laar, MD |
| 02:30 PM - 02:42 PM MDT | Abstract |
002 - Cognito’s non-invasive medical device demonstrates durable effects on activities of daily living through OVERTURE open-label extension study.
Ralph Z. Kern, MD |
| 02:42 PM - 03:00 PM MDT | Discussion |
Discussion and Panel Q&A
Joshua M. Shulman, MD, PhD, FAAN, Viviana Gradinaru, PhD, Raag Airan, Aryn Gittis |
| Evan Hempel | No disclosure on file |
| Joseph Massey | No disclosure on file |
| Aristide Merola, MD, PhD | Dr. Merola has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Merola has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Merola has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. |
| Suzanne Hendrix, PhD | Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara. |
| Brent Vaughan | No disclosure on file |
| Waldy San Sebastian | No disclosure on file |
| Adrian Kells | No disclosure on file |
| Chadwick W. Christine, MD, FAAN | The institution of Dr. Christine has received research support from Michael J Fox Foundation for Parkinson's Research. The institution of Dr. Christine has received research support from Aspen Neurosciences. The institution of Dr. Christine has received research support from ASK BIo. The institution of Dr. Christine has received research support from Bayer. |
| Chandran Seshagiri | No disclosure on file |
| Alyssa Boasso | No disclosure on file |
| Nicolás Phielipp, MD, FAAN | The institution of Dr. Phielipp has received research support from Asklepius Biopharmaceuticals. The institution of Dr. Phielipp has received research support from Aspen Therapeutics. |
| Paul Larson | No disclosure on file |
| Raag Airan | No disclosure on file |
| Viviana Gradinaru, PhD | Viviana Gradinaru, PhD has nothing to disclose. |
| ZD Kuang | No disclosure on file |
| Ramesh Arjunji | No disclosure on file |
| Zach Malchano | Mr. Malchano has received personal compensation for serving as an employee of Cognito Therapeutics, Inc.. Mr. Malchano has received stock or an ownership interest from Cognito Therapeutics. |
| Alex Konisky | No disclosure on file |
| Ralph Z. Kern, MD | Dr. Kern has received personal compensation for serving as an employee of Cognito Therapeutics. Dr. Kern has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharmatrophix. Dr. Kern has or had stock in Cognito Therapeutics. |
| Massimo Fiandaca | No disclosure on file |
| Joshua M. Shulman, MD, PhD, FAAN | Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Helis Medical Foudation. The institution of Dr. Shulman has received research support from National Institutes of Health. |
| Aryn Gittis | No disclosure on file |
| Khalil Saikali | No disclosure on file |
| Bradley Elder | Bradley Elder has nothing to disclose. |
| Krystof Bankiewicz | No disclosure on file |
| Mihaly Hajos, PhD | Prof. Hajos has received personal compensation for serving as an employee of Cognito Therapeutics, Inc. Prof. Hajos has stock in Cognito Therapeuitcs. Prof. Hajos has stock in Biogen. Prof. Hajos has stock in Pfizer. Prof. Hajos has received intellectual property interests from a discovery or technology relating to health care. |
| Amber D. Van Laar, MD | Dr. Van Laar has received personal compensation for serving as an employee of Asklepios Biopharmaceutical. The institution of an immediate family member of Dr. Van Laar has received research support from Asklepios BioPharmaceutical Inc. |